Cargando…
Performance of a 31‐gene expression profile test in cutaneous melanomas of the head and neck
BACKGROUND: We report the performance of a gene expression profile test to classify the recurrence risk of cutaneous melanoma tumors of the head and neck as low‐risk Class 1 or high‐risk Class 2. METHODS: Of note, 157 primary head and neck cutaneous melanoma tumors were identified. Survival analyses...
Autores principales: | Gastman, Brian R., Zager, Jonathan S., Messina, Jane L., Cook, Robert W., Covington, Kyle R., Middlebrook, Brooke, Gerami, Pedram, Wayne, Jeffrey D., Leachman, Sancy, Vetto, John T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667900/ https://www.ncbi.nlm.nih.gov/pubmed/30694001 http://dx.doi.org/10.1002/hed.25473 |
Ejemplares similares
-
Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients
por: Zager, Jonathan S., et al.
Publicado: (2018) -
Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test
por: Hsueh, Eddy C., et al.
Publicado: (2017) -
Routine imaging guided by a 31-gene expression profile assay results in earlier detection of melanoma with decreased metastatic tumor burden compared to patients without surveillance imaging studies
por: Dhillon, Soneet, et al.
Publicado: (2023) -
Erratum to: Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test
por: Hsueh, Eddy C., et al.
Publicado: (2017) -
Correction: Routine imaging guided by a 31‑gene expression profile assay results in earlier detection of melanoma with decreased metastatic tumor burden compared to patients without surveillance imaging studies
por: Dhillon, Soneet, et al.
Publicado: (2023)